Page last updated: 2024-10-29

irsogladine and Cholera Infantum

irsogladine has been researched along with Cholera Infantum in 2 studies

irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt

Research Excerpts

ExcerptRelevanceReference
"Irsogladine, a mucosal protective drug, was developed in Japan for the treatment of peptic ulcer disease and acute gastritis."4.89Irsogladine: overview of the mechanisms of mucosal protective and healing- promoting actions in the gastrointestinal tract. ( Akagi, M; Amagase, K; Murakami, T; Takeuchi, K, 2013)
"Alimentary mucositis is a significant complication of cancer therapy, with important clinical and economic implications."2.43Anti-inflammatory agents in the management of alimentary mucositis. ( Bensadoun, RJ; Keefe, D; Lalla, RV; Schubert, MM, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akagi, M1
Amagase, K1
Murakami, T1
Takeuchi, K1
Lalla, RV1
Schubert, MM1
Bensadoun, RJ1
Keefe, D1

Reviews

2 reviews available for irsogladine and Cholera Infantum

ArticleYear
Irsogladine: overview of the mechanisms of mucosal protective and healing- promoting actions in the gastrointestinal tract.
    Current pharmaceutical design, 2013, Volume: 19, Issue:1

    Topics: Animals; Anti-Ulcer Agents; Gastric Mucosa; Gastritis; Gastrointestinal Diseases; Helicobacter Infec

2013
Anti-inflammatory agents in the management of alimentary mucositis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2006, Volume: 14, Issue:6

    Topics: Allopurinol; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antineoplastic Agents; Benzydamin

2006